Concepedia

Christopher S. Conner

CS

17

Publications

853

Citations

14

H-Index

1978

Active since

Affiliations

Novo Nordisk (United States)(Current)

University of Colorado Health

University of Colorado Denver

Novo Nordisk (Denmark)

University of Colorado Hospital

Christopher S. Conner is an author at Novo Nordisk (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

1978–2011

17

Publications

17

Evidence Linking Hypoglycemic Events to an Increased Risk of Acute Cardiovascular Events in Patients With Type 2 Diabetes

Stephen S. Johnston, Christopher S. Conner, Mark Aagren et al. · Diabetes Care · 2011 · 184 citations · Full text

Secondary Failure of Metformin Monotherapy in Clinical Practice

Jonathan B. Brown, Christopher S. Conner, Gregory A. Nichols · Diabetes Care · 2009 · 176 citations · Full text

A comparison of preferences for two GLP-1 products – liraglutide and exenatide – for the treatment of type 2 diabetes

Michael R. Polster, Elaine Zanutto, Susan McDonald et al. · Journal of Medical Economics · 2010 · 60 citations · Full text

Podophyllum: Suspected Teratogenicity from Topical Application

Michael D. Karol, Christopher S. Conner, Arthur S. Watanabe et al. · Clinical toxicology · 1980 · 56 citations

Initial nonadherence, primary failure and therapeutic success of metformin monotherapy in clinical practice

Gregory A. Nichols, Christopher S. Conner, Jonathan B. Brown · Current Medical Research and Opinion · 2010 · 48 citations

Rows per page

1–5 of 17